Donor-soluble histocompatibility antigen selectively potentiates suppressor elements while decreasing the frequency of alloantigen-specific T cytotoxic cells.
Stepkowski
S M
SM
Department of Surgery, University of Texas Medical School at Houston.
Ghobrial
R
R
Wang
B
B
Ito
Y
Y
Goto
S
S
Hamashima
T
T
Kahan
B D
BD
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000008:administration & dosage*; D007165:Immunosuppression Therapy / Q000379:methods*; D008221:Lymphoid Tissue / Q000528:radiation effects; D051381:Rats; D011915:Rats, Inbred BUF; D011920:Rats, Inbred WF; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D014019:Tissue Donors; D014184:Transplantation, Homologous
D006649:Histocompatibility Antigens; C038353:histocompatibility antigens RT, rat; D016572:Cyclosporine